{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:50:46Z","timestamp":1786992646808,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T00:00:00Z","timestamp":1700956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019124","name":"Asia University Hospital","doi-asserted-by":"publisher","award":["ASIA-110-51005"],"award-info":[{"award-number":["ASIA-110-51005"]}],"id":[{"id":"10.13039\/100019124","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019124","name":"Asia University Hospital","doi-asserted-by":"publisher","award":["ASIA-111-51003"],"award-info":[{"award-number":["ASIA-111-51003"]}],"id":[{"id":"10.13039\/100019124","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019124","name":"Asia University Hospital","doi-asserted-by":"publisher","award":["ASIA-112-51007"],"award-info":[{"award-number":["ASIA-112-51007"]}],"id":[{"id":"10.13039\/100019124","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["DMR-111-105"],"award-info":[{"award-number":["DMR-111-105"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["DMR-112-087"],"award-info":[{"award-number":["DMR-112-087"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jiph.2023.11.026","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T18:38:54Z","timestamp":1701369534000},"page":"229-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Assessment of antibiotic resistance patterns in Central Taiwan during the COVID-19 pandemic: A retrospective study"],"prefix":"10.1016","volume":"17","author":[{"given":"Yu-Wei","family":"Tseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5844-8428","authenticated-orcid":false,"given":"Chih-Chieh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7068-1652","authenticated-orcid":false,"given":"Tze-Kiong","family":"Er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jiph.2023.11.026_bib1","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012560","article-title":"SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19?","volume":"12","author":"Bengoechea","year":"2020","journal-title":"EMBO Mol Med"},{"issue":"9","key":"10.1016\/j.jiph.2023.11.026_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092744","article-title":"Antimicrobial stewardship program, COVID-19, and infection control: spread of carbapenem-resistant klebsiella pneumoniae colonization in ICU COVID-19 patients. What did not work?","volume":"9","author":"Tiri","year":"2020","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.jiph.2023.11.026_bib3","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-020-05374-z","article-title":"Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU","volume":"20","author":"Sharifipour","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.jiph.2023.11.026_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106179","article-title":"Emerging Co-pathogens: new delhi metallo-beta-lactamase producing enterobacterales infections in New York City COVID-19 patients","volume":"56","author":"Nori","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"10.1016\/j.jiph.2023.11.026_bib5","article-title":"Clinical impact of COVID-19 on multi-drug-resistant gram-negative bacilli bloodstream infections in an intensive care unit setting: two pandemics compared","volume":"11","author":"Cogliati Dezza","year":"2022","journal-title":"Antibiot (Basel)"},{"issue":"1","key":"10.1016\/j.jiph.2023.11.026_bib6","doi-asserted-by":"crossref","DOI":"10.1186\/s13756-022-01052-8","volume":"11","author":"Thoma","year":"2022","journal-title":"Antimicrob Resist Infect Control"},{"issue":"4","key":"10.1016\/j.jiph.2023.11.026_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106324","article-title":"Increased antimicrobial resistance during the COVID-19 pandemic","volume":"57","author":"Lai","year":"2021","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.jiph.2023.11.026_bib8","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cmi.2020.12.018","article-title":"Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis","volume":"27","author":"Langford","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"10.1016\/j.jiph.2023.11.026_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272375","article-title":"Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: a systematic review and meta-analysis","volume":"17","author":"Alshaikh","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jiph.2023.11.026_bib10","doi-asserted-by":"crossref","DOI":"10.1186\/s13756-022-01085-z","article-title":"Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021)","volume":"11","author":"Kariyawasam","year":"2022","journal-title":"Antimicrob Resist Infect Control"},{"issue":"7","key":"10.1016\/j.jiph.2023.11.026_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","article-title":"Antimicrobial resistance: a global multifaceted phenomenon","volume":"109","author":"Prestinaci","year":"2015","journal-title":"Pathog Glob Health"},{"key":"10.1016\/j.jiph.2023.11.026_bib12","unstructured":"Antimicrobial Resistance C: Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022, 399(10325):629\u2013655."},{"issue":"11","key":"10.1016\/j.jiph.2023.11.026_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002184","article-title":"Will 10 million people die a year due to antimicrobial resistance by 2050?","volume":"13","author":"de Kraker","year":"2016","journal-title":"PLoS Med"},{"issue":"17","key":"10.1016\/j.jiph.2023.11.026_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24173152","article-title":"Fight against antimicrobial resistance: we always need new antibacterials but for right bacteria","volume":"24","author":"Duval","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jiph.2023.11.026_bib15","article-title":"Optimising antimicrobial use in humans - review of current evidence and an interdisciplinary consensus on key priorities for research","volume":"7","author":"Charani","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jiph.2023.11.026_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.921483","article-title":"Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?","volume":"13","author":"Perez de la Lastra","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jiph.2023.11.026_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4065\/mcp.2010.0674","article-title":"Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa","volume":"86","author":"Kanj","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jiph.2023.11.026_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s13756-019-0654-8","article-title":"Antimicrobial resistance in the Asia Pacific Region: a meeting report","volume":"8","author":"Yam","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"issue":"suppl_2","key":"10.1016\/j.jiph.2023.11.026_bib19","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1093\/cid\/ciy641","article-title":"Antimicrobial stewardship in China: systems, actions and future strategies","volume":"67","author":"Xiao","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jiph.2023.11.026_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3201\/eid0802.010244","article-title":"Current status of antimicrobial resistance in Taiwan","volume":"8","author":"Hsueh","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.jiph.2023.11.026_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1153","article-title":"Evaluation of antibiotics resistance in Southern Iran in light of COVID-19 pandemic: a retrospective observational study","volume":"6","author":"Raoofi","year":"2023","journal-title":"Health Sci Rep"},{"issue":"4","key":"10.1016\/j.jiph.2023.11.026_bib22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jiph.2023.02.021","article-title":"A parallel and silent emerging pandemic: antimicrobial resistance (AMR) amid COVID-19 pandemic","volume":"16","author":"Rehman","year":"2023","journal-title":"J Infect Public Health"},{"issue":"8","key":"10.1016\/j.jiph.2023.11.026_bib23","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/S1473-3099(23)00124-X","article-title":"How can lessons from the COVID-19 pandemic enhance antimicrobial resistance surveillance and stewardship?","volume":"23","author":"Walia","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.jiph.2023.11.026_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics12010168","article-title":"Hospital Antibiotic Use during COVID-19 Pandemic in Italy","volume":"12","author":"Perrella","year":"2023","journal-title":"Antibiot"},{"issue":"5","key":"10.1016\/j.jiph.2023.11.026_bib25","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3855\/jidc.17791","article-title":"Pre- and post-COVID-19 antimicrobial resistance profile of bacterial pathogens, a comparative study in a tertiary hospital","volume":"17","author":"Taleb","year":"2023","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.jiph.2023.11.026_bib26","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64139","article-title":"Antimicrobial resistance and COVID-19: Intersections and implications","volume":"10","author":"Knight","year":"2021","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.jiph.2023.11.026_bib27","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1128\/JCM.44.3.928-933.2006","article-title":"Evaluation of the Phoenix 100 ID\/AST system and NID panel for identification of Enterobacteriaceae, Vibrionaceae, and commonly isolated nonenteric gram-negative bacilli","volume":"44","author":"O'Hara","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiph.2023.11.026_bib28","unstructured":"CLSI: Performance Standards for Antimicrobial Susceptibility Testing 32th ed. CLSI supplement M100. Clinical and Laboratory Standards Institute; 2022."},{"issue":"5","key":"10.1016\/j.jiph.2023.11.026_bib29","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jiph.2021.02.001","article-title":"Antibiotics in treatment of COVID-19 complications: a review of frequency, indications, and efficacy","volume":"14","author":"Chedid","year":"2021","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jiph.2023.11.026_bib30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ijid.2021.01.051","article-title":"Is there a need to widely prescribe antibiotics in patients hospitalized with COVID-19?","volume":"105","author":"Moretto","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"5","key":"10.1016\/j.jiph.2023.11.026_bib31","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ajic.2020.09.013","article-title":"The impact of the COVID-19 pandemic on healthcare acquired infections with multidrug resistant organisms","volume":"49","author":"Cole","year":"2021","journal-title":"Am J Infect Control"},{"issue":"1","key":"10.1016\/j.jiph.2023.11.026_bib32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jhin.2020.05.020","article-title":"Multi-drug-resistant infections in the COVID-19 era: a framework for considering the potential impact","volume":"106","author":"Dona","year":"2020","journal-title":"J Hosp Infect"},{"issue":"8","key":"10.1016\/j.jiph.2023.11.026_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9081773","article-title":"Multi-drug resistance bacterial infections in critically Ill patients admitted with COVID-19","volume":"9","author":"Pasero","year":"2021","journal-title":"Microorganisms"},{"issue":"7","key":"10.1016\/j.jiph.2023.11.026_bib34","article-title":"Multidrug resistence prevalence in COVID area","volume":"11","author":"Aurilio","year":"2021","journal-title":"Life (Basel)"},{"issue":"5","key":"10.1016\/j.jiph.2023.11.026_bib35","first-page":"313","article-title":"Colonization by multidrug-resistant microorganisms in ICU patients during the COVID-19 pandemic","volume":"45","author":"Fernandez","year":"2021","journal-title":"Med Intensiv (Engl Ed)"},{"key":"10.1016\/j.jiph.2023.11.026_bib36","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0090-2021","article-title":"Pre- and post-COVID-19 evaluation of antimicrobial susceptibility for healthcare-associated infections in the intensive care unit of a tertiary hospital","volume":"54","author":"Gaspar","year":"2021","journal-title":"Rev Soc Bras Med Trop"},{"issue":"19","key":"10.1016\/j.jiph.2023.11.026_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph191911931","article-title":"Antibiotic resistance during COVID-19: a systematic review","volume":"19","author":"Sulayyim","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"10.1016\/j.jiph.2023.11.026_bib38","article-title":"Impact of COVID-19 on antimicrobial consumption and spread of multidrug-resistance in bacterial infections","volume":"11","author":"Jeon","year":"2022","journal-title":"Antibiot (Basel)"},{"issue":"1","key":"10.1016\/j.jiph.2023.11.026_bib39","doi-asserted-by":"crossref","DOI":"10.1186\/s13756-022-01159-y","article-title":"Assessment of antibiotic resistance changes during the Covid-19 pandemic in northeast of Iran during 2020-2022: an epidemiological study","volume":"11","author":"Khoshbakht","year":"2022","journal-title":"Antimicrob Resist Infect Control"},{"issue":"3","key":"10.1016\/j.jiph.2023.11.026_bib40","first-page":"338","article-title":"Increment antimicrobial resistance during the COVID-19 pandemic: results from the invifar network","volume":"28","author":"Lopez-Jacome","year":"2022","journal-title":"Micro Drug Resist"},{"key":"10.1016\/j.jiph.2023.11.026_bib41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jgar.2018.11.027","article-title":"Epidemiological investigation of an Acinetobacter baumannii outbreak using core genome multilocus sequence typing","volume":"17","author":"Venditti","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"issue":"17","key":"10.1016\/j.jiph.2023.11.026_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11175208","article-title":"The burden of carbapenem-resistant acinetobacter baumannii in ICU COVID-19 patients: a regional experience","volume":"11","author":"Montrucchio","year":"2022","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.jiph.2023.11.026_bib43","first-page":"390","article-title":"Comparative study of multidrug-resistant bacterial infections in hospitals and community settings in the region of Monastir - Tunisia","volume":"100","author":"Rhim","year":"2022","journal-title":"Tunis Med"},{"key":"10.1016\/j.jiph.2023.11.026_bib44","article-title":"Major bloodstream infection-causing bacterial pathogens and their antimicrobial resistance in South Korea, 2017-2019: phase I Report From Kor-GLASS","volume":"12","author":"Kim","year":"2021","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.jiph.2023.11.026_bib45","doi-asserted-by":"crossref","DOI":"10.1186\/s13756-020-00819-1","article-title":"Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis","volume":"9","author":"Li","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.jiph.2023.11.026_bib46","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.2147\/IDR.S299742","article-title":"Screening of antimicrobial resistance genes and epidemiological features in hospital and community-associated carbapenem-resistant Pseudomonas aeruginosa Infections","volume":"14","author":"Copur Cicek","year":"2021","journal-title":"Infect Drug Resist"},{"issue":"3","key":"10.1016\/j.jiph.2023.11.026_bib47","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijantimicag.2019.06.009","article-title":"Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018","volume":"54","author":"Lee","year":"2019","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.jiph.2023.11.026_bib48","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jmii.2014.01.005","article-title":"Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: Prevalence, risk factors, and impact on outcome of infections","volume":"49","author":"Lin","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"10.1016\/j.jiph.2023.11.026_bib49","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-017-1252-9","article-title":"Methicillin-resistant Staphylococcus aureus emerged long before the introduction of methicillin into clinical practice","volume":"18","author":"Harkins","year":"2017","journal-title":"Genome Biol"},{"issue":"2","key":"10.1016\/j.jiph.2023.11.026_bib50","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/QCO.0000000000000813","article-title":"Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?","volume":"35","author":"Bassetti","year":"2022","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"10.1016\/j.jiph.2023.11.026_bib51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3390\/pathophysiology29030032","article-title":"Pathophysiology of methicillin-resistant Staphylococcus aureus superinfection in COVID-19 patients","volume":"29","author":"Habib","year":"2022","journal-title":"Pathophysiology"},{"issue":"10","key":"10.1016\/j.jiph.2023.11.026_bib52","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.ajic.2021.06.005","article-title":"Risk factors for isolation of multi-drug resistant organisms in coronavirus disease 2019 pneumonia: a multicenter study","volume":"49","author":"Son","year":"2021","journal-title":"Am J Infect Control"},{"issue":"11","key":"10.1016\/j.jiph.2023.11.026_bib53","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s100960000390","article-title":"European VRESG: Prevalence of vancomycin-resistant enterococci in Europe","volume":"19","author":"Schouten","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.jiph.2023.11.026_bib54","first-page":"1131","article-title":"Correlation between nosocomial carriage of vancomycin-resistant enterococci and antimicrobial use in Taiwan","volume":"104","author":"Lee","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jiph.2023.11.026_bib55","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/biomedicines10051122","article-title":"Descriptive analysis of circulating antimicrobial resistance genes in vancomycin-resistant enterococcus (VRE) during the COVID-19 Pandemic","volume":"10","author":"Toc","year":"2022","journal-title":"Biomedicines"},{"issue":"Supplement_2","key":"10.1016\/j.jiph.2023.11.026_bib56","doi-asserted-by":"crossref","first-page":"S294","DOI":"10.1093\/cid\/ciac517","article-title":"Antibiotic-resistant infections among inpatients with coronavirus disease 2019 (COVID-19) in US hospitals","volume":"75","author":"Baggs","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jiph.2023.11.026_bib57","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-021-06219-z","article-title":"Reducing the use of empiric antibiotic therapy in COVID-19 on hospital admission","volume":"21","author":"Pettit","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiph.2023.11.026_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmii.2022.08.003","article-title":"Trend in healthcare-associated infections due to vancomycin-resistant Enterococcus at a hospital in the era of COVID-19: More than hand hygiene is needed","author":"Fukushige","year":"2022","journal-title":"J Microbiol Immunol Infect"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187603412300432X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187603412300432X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:23:51Z","timestamp":1761751431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187603412300432X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S187603412300432X"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2023.11.026","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of antibiotic resistance patterns in Central Taiwan during the COVID-19 pandemic: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2023.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}]}}